Bai Jun, Head of Small Nucleic Acid Therapeutics at Haichang Bio, Joins IBI EXPO Suzhou 2025 as Co-Organizer
Haichang Biotech
Innovative Formulation Developer
The plan for the year starts in spring. As the beginning of the four seasons, spring unfolds in an orderly fashion, making it the perfect time to embark on a new journey.March 1, 2025 to March 2, 2025，IBI EXPO 2025 (3rd) Biologics Innovation ConferenceWill be inSuzhou International Expo CenterGrandly held.
Conference FocusCell therapy, gene therapy, novel antibody drugs, stem cells and regenerative medicine, gene editing, nucleic acid drugs, exosomes, novel deliveryetc.In the frontier field of biopharmaceutical technology, fromNew Drug Development, Non-clinical Evaluation, CMC Development, Drug Registration, Clinical Trials, Commercial Transformationetc.The entire lifecycle of biopharmaceuticals will be covered, and leading enterprises from various细分 fields in China, emerging companies, as well as representatives of leading companies that have made significant progress in the past year will be invited to present an unprecedented annual event in the field of biopharmaceutical innovation.
To promote the development of the industry,IBI EXPO 2025 (3rd) Biopharmaceutical Innovation ConferenceTheThe 4th Nucleic Acid Drug Development Forum`, Special`Small Nucleic Acid Drugs, and invitedJun Bai, Head of the Small Nucleic Acid Drug Department at Haichang Biotech R&D CenterAct as a co-planner, looking forward to your participation.
Introduction to the Planner
Bai Jun, Head of the Small Nucleic Acid Drug Department at Haichang Biotech R&D Center
PhD graduated from the College of Life Sciences, Zhejiang University, currently working at the Haichang Biotech New Drug Research and Development Center, responsible for the development of small nucleic acid drug pipelines. Published 8 SCI-indexed papers, 3 AACR conference abstracts, and applied for more than ten invention patents. Current research areas include the application of siRNA, ASO, microRNA, and other drugs in chronic diseases, cancer, and medical aesthetics. Skilled in the design and early development of small nucleic acid drugs.
The 4th Nucleic Acid Drug Development Forum
Key Content and Hot Topics
Small Nucleic Acid (Extrahepatic) Targeted Delivery
Multi-Tissue Delivery System to Enhance ASO Drugability
Development of a New Generation of ASO Drugs for the Treatment of DMD
Development and Application Progress of RNA Editing Technologies Based on Small Nucleic Acid Drugs
High-Throughput Data and AI Algorithm-Driven Innovation in Small Nucleic Acid Drugs
Roundtable Discussion:Paving the Commercialization Path for Small Nucleic Acid Drugs
This forum is for enterprises and research institutions guestsOpen Report Seat, to showcase the latest achievements to the industry and create more cooperation opportunities. Welcome to register!
Contact:
Teacher Wang 18717836231
Conference Content
Forum Schedule
Content Collaboration Recruitment
Thematic Planning, Speech Reports, Project Roadshows...
Contact for more information
Teacher Wang 18701871600
Business Sponsorship Reservation
Free booths, forum naming rights, cocktail party sponsorship...
Contact for more information
Teacher Wang 18717836231
Teacher Sun 15801839775
Early Bird Registration Now Open
Single Session Ticket LimitFree 1000 pieces, as of December 1
Contact for more information
Teacher Yang 15517201185
review
Previous IssuesReview
2024 IBI EXPO
International Biopharmaceutical Innovation Conference
IBI EXPO 2024 Biomedical Innovation Conference Grandly Opens, Joint Efforts to Build the Future
IBI EXPO 2024 Day 1 Recap: A Day Full of Highlights, Continuing the Splendor Today!
See You Next Year! 2024 IBI EXPO Biotech Innovation Conference Concludes Successfully
2023 IBI EXPO
International Biopharmaceutical Innovation Conference
IBI EXPO 2023 International Biopharmaceutical Innovation Conference Grandly Opens, Gathering of Multiple Parties to Shape the Future
2023 IBI EXPO | ADC in the Era of Target Saturation: Where is the Future? A Discussion on the Iteration of New Technologies, New Targets, and New Linkers
2023 IBI EXPO | From Drug Development to Industrialization: Opportunities and Challenges in Nucleic Acid and Stem Cell Development
